ArticleCurrent Alzheimer research2012

Targeting phospho-Ser422 by active Tau Immunotherapy in the THYTau22 mouse model: a suitable therapeutic approach.

Laetitia Troquier et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.